Food And Drug Administration-Blood Clot Preventer-Bristol-Myers Squibb-Health Regulators

Bristol/Pfizer clot preventer delayed in U.S

(Reuters) - A closely watched blood clot preventer from Bristol-Myers Squibb Co and Pfizer Inc has failed to win approval from U.S. health regulators, the companies said on Monday. Investors have been awaiting a decision on the drug, Eliquis, by the Food And Drug Administration by the end of the month. The FDA notification did not require the companies to complete any new studies, the companies said, which could mean only a short delay before the drug wins approval. Rather, the agency wants more information on data management and verification from a key clinical trial supporting the medicine. ... read more..

source:http://yhoo.it/MmEDll

Erectile Dysfunction-Pfizer Inc-Vivus Inc-Avanafil-Viagra

FDA approves Vivus's fast-acting Viagra rival

A box of Viagra is seen in a pharmacy in Toronto

NEW YORK (Reuters) - Men with erectile dysfunction may not have to plan for sex as far in advance anymore after Vivus Inc won U.S. approval for avanafil, its faster acting rival to Viagra. Avanafil, which will be sold under the brand name Stendra, is the first new drug in the category in a decade. The drug -- which will compete with Pfizer Inc's Viagra, Eli Lilly's Cialis and Levitra, sold by GlaxoSmithKline and Bayer -- gives Vivus, which has struggled to bring a weight loss drug to market, a potentially lucrative commercial product. ... read more..

source:http://yhoo.it/J7mB4j